Observational studyDiabetes, obesity & metabolism2026

One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population.

Louise A Donnelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.